Your browser doesn't support javascript.
loading
Spironolactone lowers portal hypertension by inhibiting liver fibrosis, ROCK-2 activity and activating NO/PKG pathway in the bile-duct-ligated rat.
Luo, Wei; Meng, Ying; Ji, Hong-Li; Pan, Chun-Qiu; Huang, Shan; Yu, Chang-Hui; Xiao, Li-Ming; Cui, Kai; Ni, Shu-Yuan; Zhang, Zhen-Shu; Li, Xu.
Affiliation
  • Luo W; Guangdong Provincial Key Laboratory of Gastroenterology, Department of Gastroenterology, Southern Medical University, Nanfang Hospital, Guangzhou, China.
PLoS One ; 7(3): e34230, 2012.
Article in En | MEDLINE | ID: mdl-22479572
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cyclic GMP-Dependent Protein Kinases / Rho-Associated Kinases / Liver / Liver Cirrhosis / Nitric Oxide Limits: Animals Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2012 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cyclic GMP-Dependent Protein Kinases / Rho-Associated Kinases / Liver / Liver Cirrhosis / Nitric Oxide Limits: Animals Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2012 Document type: Article Affiliation country: Country of publication: